Table 3.
The Weekly Mean VAS Scores from the Start of Treatment (First Week) to Five Weeks Later (Sixth Week) in the Elcatonin and Placebo Groups
| Group | Week | p Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | Time | Group | Time×Group | ||
| Pain at rest | Elcatonin | 3.00 ± 2.60 | 2.56 ± 2.28 | 1.16 ±1.14 | 0.73 ± 1.15 | 0.39 ± 0.68 | 0.20 ± 0.35 | <0.001 | 0.969 | 0.992 |
| Placebo | 2.83 ± 2.65 | 2.81 ± 2.87 | 1.03 ± 1.31 | 0.70 ±0.93 | 0.43 ± 0.55 | 0.34 ± 0.59 | ||||
| Difference (95%CI) | 0.17 (-1.73, 2.07) | -0.24 (-2.14, 1.65) | 0.13 (-0.77, 1.02) | 0.03 (-0.72, 0.79) | -0.03 (-0.48, 0.41) | -0.14 (-0.50, 0.22) | ||||
| Pain at motion | Elcatonin | 6.91 ± 1.93 | 4.62 ± 1.89 | 3.06 ± 2.05 | 1.83 ± 1.84 | 0.77 ± 0.83 | 0.38 ± 0.49 | <0.001 | 0.037 | 0.542 |
| Placebo | 7.04 ± 2.44 | 5.47 ± 3.28 | 4.87 ± 2.76 | 3.03 ± 3.09 | 2.05 ± 2.18 | 1.77 ± 2.09 | ||||
| Difference (95%CI) | -0.13 (-1.74, 1.48) | -0.86 (-2.86, 1.14) | -1.81 (-3.59, -0.02) | -1.20 (-3.09, 0.69) | -1.28 (-2.53, -0.02) | -1.40 (-2.57, -0.22) | ||||
Values are listed as the mean ± standard deviation. 95% CI; 95% confidence interval